Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapy resistance mediated by exosomes.
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Steinbichler TB, et al. Among authors: skvortsov s. Mol Cancer. 2019 Mar 30;18(1):58. doi: 10.1186/s12943-019-0970-x. Mol Cancer. 2019. PMID: 30925921 Free PMC article. Review.
Screening and identification of molecular targets for cancer therapy.
Abdelmoez A, Coraça-Huber DC, Thurner GC, Debbage P, Lukas P, Skvortsov S, Skvortsova II. Abdelmoez A, et al. Among authors: skvortsov s. Cancer Lett. 2017 Feb 28;387:3-9. doi: 10.1016/j.canlet.2016.03.002. Epub 2016 Mar 8. Cancer Lett. 2017. PMID: 26968248 Review.
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
Skvortsova I, Skvortsov S, Raju U, Stasyk T, Riesterer O, Schottdorf EM, Popper BA, Schiestl B, Eichberger P, Debbage P, Neher A, Bonn GK, Huber LA, Milas L, Lukas P. Skvortsova I, et al. Among authors: skvortsov s. Radiother Oncol. 2010 Jul;96(1):108-15. doi: 10.1016/j.radonc.2010.04.017. Epub 2010 May 5. Radiother Oncol. 2010. PMID: 20451273
Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC).
Skvortsov S, Dudás J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, Schartinger VH, Maier H, Hall J, Debbage P, Riechelmann H, Lukas P, Skvortsova I; EORTC PathoBiology Group. Skvortsov S, et al. Br J Cancer. 2014 May 27;110(11):2677-87. doi: 10.1038/bjc.2014.221. Epub 2014 May 1. Br J Cancer. 2014. PMID: 24786604 Free PMC article.
Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients?
Arnold CR, Lindner AK, Schachtner G, Tulchiner G, Tulchiner N, Mangesius J, Maffei M, Horninger W, Kouvaiou O, Lukas P, Ganswindt U, Pichler R, Skvortsov S. Arnold CR, et al. Among authors: skvortsov s. Strahlenther Onkol. 2022 Jan;198(1):25-32. doi: 10.1007/s00066-021-01837-7. Epub 2021 Aug 19. Strahlenther Onkol. 2022. PMID: 34414475 Free PMC article.
84 results